Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 4:07 PM UTC
| NCT Number | NCT06953960 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 325 participants |
| Active Locations | 12 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | September 14, 2026 (Sep 14, 2026) |
As of October 14, 2026: Clinical trial NCT06953960 is currently recruiting participants. This phase1 study for multiple myeloma is actively seeking new participants at 12 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06953960 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06953960 was last updated Sep 14, 2026 (September 14, 2026). HelloStudys verifies this status automatically.